Clinical Trial Update: Risk-Targeted Behavioural Activation for the Management of Treatment-Resistant Depression. [NA]

View source ↗

Summary

A clinical trial update on risk-targeted behavioural activation for managing treatment-resistant depression. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Snippet

Sponsor: McGill University | Conditions: Treatment Resistant Depression (TRD) | NA | Status: COMPLETED